Retraction for Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation

Hanchen Xu; Kevin Van der Jeught; Zhuolong Zhou; Lu Zhang; Tao Yu; Yifan Sun; Yujing Li; Changlin Wan; Ka Man So; Degang Liu; Michael Frieden; Yuanzhang Fang; Amber L. Mosley; Xiaoming He; Xinna Zhang; George Earl Sandusky; Yunlong Liu; Samy O. Meroueh; Chi Zhang; Aruna B. Wijeratne; Cheng Huang; Guang Ji; Xiongbin Lu

doi:10.1172/jci202473

Retraction for Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation

Journal of Clinical Investigation 2026 Open access

Read full text

Authors: Hanchen Xu, Kevin Van der Jeught, Zhuolong Zhou, Lu Zhang, Tao Yu, Yifan Sun, Yujing Li, Changlin Wan, Ka Man So, Degang Liu, Michael Frieden, Yuanzhang Fang

+11 more

Amber L. Mosley, Xiaoming He, Xinna Zhang, George Earl Sandusky, Yunlong Liu, Samy O. Meroueh, Chi Zhang, Aruna B. Wijeratne, Cheng Huang, Guang Ji, Xiongbin Lu

DOI: 10.1172/jci202473

Cited by: 0

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Sesquiterpenes and Asteraceae Studies

Publication details

Journal / source: Journal of Clinical Investigation
Volume: 136
Issue: 2
Publication date: 15 January 2026
Language: EN